Annual CFI
$87.36 M
-$22.23 M-20.29%
31 December 2023
Summary:
Inovio Pharmaceuticals annual cash flow from investing activities is currently $87.36 million, with the most recent change of -$22.23 million (-20.29%) on 31 December 2023. During the last 3 years, it has risen by +$146.15 million (+248.58%). INO annual CFI is now -20.29% below its all-time high of $109.59 million, reached on 31 December 2022.INO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$14.08 M
+$4.11 M+41.25%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly cash flow from investing activities is currently $14.08 million, with the most recent change of +$4.11 million (+41.25%) on 30 September 2024. Over the past year, it has increased by +$19.57 million (+356.25%). INO quarterly CFI is now -74.84% below its all-time high of $55.96 million, reached on 30 September 2021.INO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$89.37 M
+$19.57 M+28.04%
30 September 2024
Summary:
Inovio Pharmaceuticals TTM cash flow from investing activities is currently $89.37 million, with the most recent change of +$19.57 million (+28.04%) on 30 September 2024. Over the past year, it has dropped by -$32.04 million (-26.39%). INO TTM CFI is now -47.88% below its all-time high of $171.46 million, reached on 30 June 2023.INO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.3% | +356.3% | -26.4% |
| 3 y3 years | +248.6% | -74.8% | +151.8% |
| 5 y5 years | +105.9% | +70.2% | +826.8% |
INO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -20.3% | +149.8% | -74.8% | +236.6% | -47.9% | +151.0% |
| 5 y | 5 years | -20.3% | +149.8% | -74.8% | +105.1% | -47.9% | +131.7% |
| alltime | all time | -20.3% | +149.8% | -74.8% | +105.1% | -47.9% | +131.7% |
Inovio Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $14.08 M(+41.3%) | $89.37 M(+28.0%) |
| June 2024 | - | $9.97 M(-78.0%) | $69.80 M(-38.6%) |
| Mar 2024 | - | $45.38 M(+127.6%) | $113.74 M(+30.2%) |
| Dec 2023 | $87.36 M(-20.3%) | $19.94 M(-463.0%) | $87.36 M(-28.1%) |
| Sept 2023 | - | -$5.49 M(-110.2%) | $121.41 M(-29.2%) |
| June 2023 | - | $53.91 M(+183.7%) | $171.46 M(+59.9%) |
| Mar 2023 | - | $19.00 M(-64.8%) | $107.25 M(-2.1%) |
| Dec 2022 | $109.59 M(-162.5%) | $54.00 M(+21.2%) | $109.59 M(+123.2%) |
| Sept 2022 | - | $44.56 M(-532.4%) | $49.09 M(-18.8%) |
| June 2022 | - | -$10.30 M(-148.3%) | $60.49 M(-50.0%) |
| Mar 2022 | - | $21.33 M(-428.5%) | $121.10 M(-169.1%) |
| Dec 2021 | -$175.34 M(+198.2%) | -$6.49 M(-111.6%) | -$175.34 M(+1.6%) |
| Sept 2021 | - | $55.96 M(+11.2%) | -$172.57 M(-8.9%) |
| June 2021 | - | $50.31 M(-118.3%) | -$189.41 M(-32.9%) |
| Mar 2021 | - | -$275.12 M(+7303.3%) | -$282.10 M(+379.8%) |
| Dec 2020 | -$58.80 M(+550.0%) | -$3.72 M(-109.5%) | -$58.80 M(+31.7%) |
| Sept 2020 | - | $39.11 M(-192.3%) | -$44.64 M(-40.9%) |
| June 2020 | - | -$42.39 M(-18.2%) | -$75.49 M(+555.5%) |
| Mar 2020 | - | -$51.81 M(-596.5%) | -$11.52 M(+27.3%) |
| Dec 2019 | -$9.04 M(-121.3%) | $10.43 M(+26.2%) | -$9.04 M(-26.4%) |
| Sept 2019 | - | $8.27 M(-61.7%) | -$12.30 M(+100.0%) |
| June 2019 | - | $21.59 M(-143.8%) | -$6.15 M(-81.8%) |
| Mar 2019 | - | -$49.34 M(-786.9%) | -$33.72 M(-179.5%) |
| Dec 2018 | $42.42 M(-252.4%) | $7.18 M(-50.2%) | $42.42 M(-14.9%) |
| Sept 2018 | - | $14.42 M(-340.9%) | $49.82 M(-365.6%) |
| June 2018 | - | -$5.98 M(-122.3%) | -$18.76 M(-2.3%) |
| Mar 2018 | - | $26.80 M(+83.8%) | -$19.20 M(-31.0%) |
| Dec 2017 | -$27.83 M(-271.0%) | $14.58 M(-126.9%) | -$27.83 M(-14.4%) |
| Sept 2017 | - | -$54.16 M(+743.2%) | -$32.49 M(-205.7%) |
| June 2017 | - | -$6.42 M(-135.4%) | $30.74 M(-11.6%) |
| Mar 2017 | - | $18.17 M(+83.2%) | $34.78 M(+113.7%) |
| Dec 2016 | $16.27 M(-129.7%) | $9.92 M(+9.3%) | $16.27 M(-209.4%) |
| Sept 2016 | - | $9.07 M(-481.0%) | -$14.87 M(-42.6%) |
| June 2016 | - | -$2.38 M(+604.2%) | -$25.92 M(-50.9%) |
| Mar 2016 | - | -$338.20 K(-98.4%) | -$52.83 M(-3.6%) |
| Dec 2015 | -$54.82 M(+53.1%) | -$21.22 M(+971.3%) | -$54.82 M(-3.5%) |
| Sept 2015 | - | -$1.98 M(-93.2%) | -$56.82 M(-12.8%) |
| June 2015 | - | -$29.29 M(+1157.2%) | -$65.16 M(+67.7%) |
| Mar 2015 | - | -$2.33 M(-90.0%) | -$38.86 M(+8.5%) |
| Dec 2014 | -$35.81 M(+287.7%) | -$23.22 M(+124.9%) | -$35.81 M(+106.5%) |
| Sept 2014 | - | -$10.32 M(+244.9%) | -$17.34 M(+140.7%) |
| June 2014 | - | -$2.99 M(-516.4%) | -$7.20 M(-15.5%) |
| Mar 2014 | - | $718.60 K(-115.1%) | -$8.53 M(-7.7%) |
| Dec 2013 | -$9.24 M(-275.1%) | -$4.74 M(+2471.8%) | -$9.24 M(+358.8%) |
| Sept 2013 | - | -$184.50 K(-95.7%) | -$2.01 M(-224.7%) |
| June 2013 | - | -$4.32 M(<-9900.0%) | $1.61 M(-73.4%) |
| Mar 2013 | - | $10.80 K(-99.6%) | $6.07 M(+15.1%) |
| Dec 2012 | $5.28 M(-148.4%) | $2.48 M(-28.0%) | $5.28 M(-222.4%) |
| Sept 2012 | - | $3.44 M(+2402.5%) | -$4.31 M(-44.6%) |
| June 2012 | - | $137.60 K(-117.5%) | -$7.77 M(-22.6%) |
| Mar 2012 | - | -$784.30 K(-89.0%) | -$10.05 M(-7.8%) |
| Dec 2011 | -$10.90 M | -$7.11 M(>+9900.0%) | -$10.90 M(+619.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$21.10 K(-99.0%) | -$1.52 M(-136.8%) |
| June 2011 | - | -$2.14 M(+30.6%) | $4.12 M(-76.9%) |
| Mar 2011 | - | -$1.64 M(-171.8%) | $17.84 M(+56.0%) |
| Dec 2010 | $11.44 M(+690.7%) | $2.28 M(-59.4%) | $11.44 M(+25.3%) |
| Sept 2010 | - | $5.61 M(-51.5%) | $9.13 M(+160.3%) |
| June 2010 | - | $11.58 M(-244.1%) | $3.51 M(-153.7%) |
| Mar 2010 | - | -$8.04 M(>+9900.0%) | -$6.53 M(-551.3%) |
| Dec 2009 | $1.45 M(-50.4%) | -$33.60 K(+646.7%) | $1.45 M(+5.1%) |
| Sept 2009 | - | -$4500.00(-100.3%) | $1.38 M(+18.9%) |
| June 2009 | - | $1.55 M(-2537.8%) | $1.16 M(-53.0%) |
| Mar 2009 | - | -$63.50 K(-38.6%) | $2.46 M(-15.6%) |
| Dec 2008 | $2.92 M(-202.4%) | -$103.40 K(-53.7%) | $2.92 M(-60.0%) |
| Sept 2008 | - | -$223.40 K(-107.8%) | $7.29 M(-26.3%) |
| June 2008 | - | $2.85 M(+627.7%) | $9.88 M(-335.4%) |
| Mar 2008 | - | $391.80 K(-90.8%) | -$4.20 M(+47.4%) |
| Dec 2007 | -$2.85 M(-82.3%) | $4.27 M(+80.0%) | -$2.85 M(-83.1%) |
| Sept 2007 | - | $2.37 M(-121.1%) | -$16.89 M(+4.7%) |
| June 2007 | - | -$11.23 M(-744.7%) | -$16.14 M(+633.5%) |
| Mar 2007 | - | $1.74 M(-117.8%) | -$2.20 M(-86.3%) |
| Dec 2006 | -$16.07 M(+422.3%) | -$9.77 M(-412.8%) | -$16.07 M(+149.4%) |
| Sept 2006 | - | $3.12 M(+15.4%) | -$6.44 M(-33.8%) |
| June 2006 | - | $2.71 M(-122.3%) | -$9.74 M(-22.5%) |
| Mar 2006 | - | -$12.12 M(+7971.0%) | -$12.56 M(+308.3%) |
| Dec 2005 | -$3.08 M(+600.5%) | -$150.20 K(-12.4%) | -$3.08 M(+2.6%) |
| Sept 2005 | - | -$171.50 K(+51.4%) | -$3.00 M(+1.3%) |
| June 2005 | - | -$113.30 K(-95.7%) | -$2.96 M(+0.1%) |
| Mar 2005 | - | -$2.64 M(+3517.4%) | -$2.96 M(+573.0%) |
| Dec 2004 | -$439.10 K(+29.1%) | -$73.00 K(-44.7%) | -$439.10 K(-9.0%) |
| Sept 2004 | - | -$131.90 K(+20.3%) | -$482.40 K(+7.2%) |
| June 2004 | - | -$109.60 K(-12.0%) | -$450.00 K(+6.9%) |
| Mar 2004 | - | -$124.60 K(+7.1%) | -$420.80 K(+23.7%) |
| Dec 2003 | -$340.10 K(-12.6%) | -$116.30 K(+16.9%) | -$340.10 K(-154.4%) |
| Sept 2003 | - | -$99.50 K(+23.8%) | $624.70 K(-61.0%) |
| June 2003 | - | -$80.40 K(+83.1%) | $1.60 M(-579.5%) |
| Mar 2003 | - | -$43.90 K(-105.2%) | -$334.00 K(-14.2%) |
| Dec 2002 | -$389.20 K(-115.8%) | $848.50 K(-3.3%) | -$389.10 K(-68.6%) |
| Sept 2002 | - | $877.30 K(-143.5%) | -$1.24 M(-47.5%) |
| June 2002 | - | -$2.02 M(+1936.3%) | -$2.36 M(-198.8%) |
| Mar 2002 | - | -$99.00 K(-59.3%) | $2.39 M(-508.8%) |
| Dec 2001 | $2.46 M(-173.2%) | - | - |
| Sept 2001 | - | -$243.50 K(-108.9%) | -$584.00 K(+26.3%) |
| June 2001 | - | $2.73 M(-220.4%) | -$462.40 K(-86.3%) |
| Mar 2001 | - | -$2.27 M(+182.6%) | -$3.36 M(-167.0%) |
| Mar 2001 | -$3.36 M(+328.5%) | - | - |
| Dec 2000 | - | -$802.50 K(+558.3%) | $5.02 M(-37.4%) |
| Sept 2000 | - | -$121.90 K(-29.1%) | $8.02 M(-1159.6%) |
| June 2000 | - | -$171.90 K(-102.8%) | -$757.00 K(-3.6%) |
| Mar 2000 | -$785.10 K(-1.9%) | $6.11 M(+178.0%) | -$785.10 K(-88.6%) |
| Dec 1999 | - | $2.20 M(-124.7%) | -$6.90 M(-24.2%) |
| Sept 1999 | - | -$8.90 M(+4350.0%) | -$9.10 M(+4450.0%) |
| June 1999 | - | -$200.00 K | -$200.00 K |
| Mar 1999 | -$800.00 K | - | - |
FAQ
- What is Inovio Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual CFI year-on-year change?
- What is Inovio Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly CFI year-on-year change?
- What is Inovio Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals TTM CFI year-on-year change?
What is Inovio Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of INO is $87.36 M
What is the all time high annual CFI for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual cash flow from investing activities is $109.59 M
What is Inovio Pharmaceuticals annual CFI year-on-year change?
Over the past year, INO annual cash flow from investing activities has changed by -$22.23 M (-20.29%)
What is Inovio Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of INO is $14.08 M
What is the all time high quarterly CFI for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly cash flow from investing activities is $55.96 M
What is Inovio Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, INO quarterly cash flow from investing activities has changed by +$19.57 M (+356.25%)
What is Inovio Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of INO is $89.37 M
What is the all time high TTM CFI for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high TTM cash flow from investing activities is $171.46 M
What is Inovio Pharmaceuticals TTM CFI year-on-year change?
Over the past year, INO TTM cash flow from investing activities has changed by -$32.04 M (-26.39%)